Molecular determinants and regulation of Leishmania virulence

Kinetoplastid Biology and Disease

Volumn 1, Issue , 2002, Pages

  Chang, Kwang Poo ^a   McGwire, Bradford S ^b  

^a University of the Health Sciences   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; PARASITE ANTIGEN; VACCINE;

ANTIGEN EXPRESSION; CELL SURFACE; CONVALESCENCE; DEATH; DISEASE COURSE; ENVIRONMENTAL FACTOR; FATALITY; HEREDITY; HOST; HOST PARASITE INTERACTION; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INFECTION; INFECTION CONTROL; LEISHMANIA; NONHUMAN; PARASITE VIRULENCE; PHENOTYPE; REGULATORY MECHANISM; REVIEW; SYMPTOMATOLOGY;

EID: 2442675705     PISSN: 14759292     EISSN: None     Source Type: Journal    
DOI: 10.1186/1475-9292-1-1     Document Type: Review

References (27)

1. Chang KP, Chaudhuri G, Fong D: Molecular determinants of Leishmania virulence. Annu Rev Microbiol 1990, 44:499-529
2. Blackwell JM: Genetic susceptibility to leishmanial infections: studies in mice and man. Parasitology 1996, 112:S67-74
3. Titus RG, Ribeiro JM: Salivary gland lysates from the sand fly Lutzomyia longipalpis enhance Leishmania infectivity. Science 1988, 239:1306-1308
4. Chang KP, Dwyer DM: Multiplication of a human parasite (Leishmania donovani) in phagolysosomes of hamster macrophages in vitro. Science 1976, 193:678-680
5. Qi H, Popov V, Soong L: Leishmania amazonensis-dendritic cell interactions in vitro and the priming of parasite-specific CD4(+) T cells in vivo. J Immunol 2001, 167:4534-4542
6. Chang KP: Leishmania infection of human skin fibroblasts in vitro: absence of phagolysosomal fusion after induced phagocytosis of promastigotes, and their intracellular transformation. Am J Trop Med Hyg 1978, 27:1084-1096
7. Bogdan C, Donhauser N, Doring R, Rollinghoff M, Diefenbach A, Rittig GM: Fibroblasts as host cells in latent leishmaniosis. J Exp Med 2000, 191:2121-2130
8. Chang KP: Cellular and molecular mechanisms of intracellular symbiosis in leishmaniasis. Intl Rev of Cytol - Suppl 1983, 14:267-305
9. Chang KP: Human cutaneous leishmania in a mouse macrophage line: propagation and isolation of intracellular parasites. Science 1980, 209:1240-1242
10. Requena JM, Alonso C, Soto M: Evolutionarily conserved proteins as prominent immunogens during Leishmania infections. Parasitol Today 2000, 16:246-250
11. McGwire BS, O'Connell WA, Chang KP, Engman DM: Extracellular release of the glycosylphosphatidylinositol (GPI)-linked Leishmania surface metalloprotease, gp63, is independent of GPI phospholipolysis. J Biol Chem 2002, 277:8802-8809
12. Brittingham A, Morrison CJ, McMaster WR, McGwire BS, Chang KP, Mosser DM: Role of the Leishmania surface protease gp63 in complement fixation, cell adhesion, and resistance to complement-mediated lysis. J Immunol 1995, 155:3102-3111
13. Chang CS, Chang KP: Monoclonal antibody affinity purification of a Leishmania membrane glycoprotein and its inhibition of leishmania-macrophage binding. Proc Natl Acad Sci USA 1986, 83:100-104
14. Russell DG, Wilhelm H: The involvement of the major surface glycoprotein (gp63) of Leishmania promastigotes in attachment to macrophages. J Immunol 1986, 136:2613-2620
15. Liu X, Chang KP: Extrachromosomal genetic complementation of surface metalloproteinase (gp63)-deficient Leishmania increases their binding to macrophages. Proc Natl Acad Sci USA 1992, 89:4991-4995
16. McGwire B, Chang KP: Genetic rescue of surface metalloproteinase (gp63)-deficiency in Leishmania amazonensis variants increases their infection of macrophages at the early phase. Mol Biochem Parasitol 1994, 66:345-347
17. Beverley SM, Turco SJ: Lipophosphoglycan (LPG) and the identification of virulence genes in the protozoan parasite Leishmania. Trends Microbiol 1998, 6:35-40
18. Chaudhuri G, Chaudhuri M, Pan A, Chang KP: Surface acid proteinase (gp63) of Leishmania mexicana. A metalloenzyme capable of protecting liposome-encapsulated proteins from phagolysosomal degradation by macrophages. J Biol Chem 1989, 264:7483-7489
19. Burns JM Jr, Shreffler WG, Benson DR, Ghalib HW, Badaro R, Reed SG: Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis. Proc Natl Acad Sci U S A 1993, 90:775-779
20. Singh S, Gilman-Sachs A, Chang KP, Reed SG: Diagnostic and prognostic value of K39 recombinant antigen in Indian leishmaniasis. J Parasitol 1995, 81:1000-1003
21. Probst P, Stromberg E, Ghalib HW, Mozel M, Badaro R, Reed SG, Webb JR: Identification and characterization of T cell-stimulating antigens from Leishmania by CD4 T cell expression cloning. J Immunol 2001, 166:498-505
22. Cunningham ML, Titus RG, Turco SJ, Beverley SM: Regulation of differentiation to the infective stage of the protozoan parasite Leishmania major by tetrahydrobiopterin. Science 2001, 292:285-287
23. Krakauer DC, Plotkin JB: Redundancy, antiredundancy, and the robustness of genomes. Proc Natl Acad Sci U S A 2002, 99:1405-1409
24. LeBowitz JH, Cruz A, Beverley SM: Thymidine kinase as a negative selectable marker in Leishmania major. Mol Biochem Parasitol 1992, 51:321-325
25. Titus RG, Gueiros-Filho FJ, de Freitas LA, Beverley SM: Development of a safe live Leishmania vaccine line by gene replacement. Proc Natl Acad Sci U S A 1995, 92:10267-10271
26. Yan S, Myler PJ, Stuart K: Tetracycline regulated gene expression in Leishmania donovani. Mol Biochem Parasitol. 2001, 112:61-9
27. Sah JF, Ito H, Kolli BK, Peterson DA, Sassa S, Chang KP: Genetic rescue of Leishmania deficiency in porphyrin biosynthesis creates mutants suitable for analysis of cellular events in uroporphyria and photodynamic therapy. J Biol Chem 2002, 277:14902-14909